Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy

Nature Protocols

Volumn 8, Issue 1, 2013, Pages 66-74

  Goeden, Nick ^a   Bonnin, Alexandre ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; EMBRYO; EX VIVO STUDY; EXPERIMENTAL DESIGN; FEMALE; FETUS CIRCULATION; GESTATION PERIOD; INCUBATION TEMPERATURE; INCUBATION TIME; INTERMETHOD COMPARISON; MATERNAL BLOOD; MOTHER FETUS RELATIONSHIP; MOUSE; NONHUMAN; PLACENTA PERFUSION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; TISSUE PREPARATION; UMBILICAL ARTERY CATHETERIZATION; UMBILICAL CORD; UMBILICAL VEIN;

ANIMALS; DISSECTION; FEMALE; MATERNAL-FETAL EXCHANGE; MICE; PERFUSION; PLACENTA; PREGNANCY;

EID: 84872013891     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2012.144     Document Type: Article

References (83)

1. Stulc, J., Stulcová, B. & Svihovec, J. Transport of calcium across the dually perfused placenta of the rat. J. Physiol. 420, 295-311 (1990). (Pubitemid 20051220)
2. Nowak-Wegzryan, A. Materno-fetal passage of nutritive and inhalant allergens across placentas of term and preterm deliveries perfused in vitro. Pediatrics 112, 460 (2003).
3. Cygalova, L.H., Hofman, J., Ceckova, M. & Staud, F. Transplacental pharmacokinetics of glyburide, rhodamine 123, and BODIPY FL prazosin: effect of drug efflux transporters and lipid solubility. J. Pharmacol. Exp. Ther. 331, 1118-1125 (2009).
4. Schneider, H., Panigel, M. & Dancis, J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am. J. Obstet. Gynecol. 114, 822-828 (1972).
5. Myren, M., Mose, T., Mathiesen, L. & Knudsen, L.E. The human placenta - an alternative for studying foetal exposure. Toxicol. In Vitro 21, 1332-1340 (2007). (Pubitemid 350026248)
6. Bond, H. et al. Artificial perfusion of the fetal circulation of the in situ mouse placenta: methodology and validation. Placenta 27, S69-S75 (2006).
7. Hauguel, S., Challier, J.C., Cedard, L. & Olive, G. Metabolism of the human placenta perfused in vitro: glucose transfer and utilization, O2 consumption, lactate and ammonia production. Pediatr. Res. 17, 729-732 (1983). (Pubitemid 13051094)
8. Ala-Kokko, T.I., Myllynen, P. & Vähäkangas, K. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology. Int. J. Obstet. Anesth. 9, 26-38 (2000). (Pubitemid 30093365)
9. Bonnin, A. et al. A transient placental source of serotonin for the fetal forebrain. Nature 472, 347-350 (2011).
10. Loughhead, A.M. et al. Placental passage of tricyclic antidepressants. Biol. Psychiatry 59, 287-290 (2006). (Pubitemid 43208977)
11. Wheeler, C.P. & Yudilevich, D.L. Transport and metabolism of adenosine in the perfused guinea-pig placenta. J. Physiol. 405, 511-526 (1988).
12. Polliotti, B.M. et al. Long-term dual perfusion of isolated human placental lobules with improved oxygenation for infectious diseases research. Placenta 17, 57-68 (1996). (Pubitemid 26108966)
13. Panigel, M. Radioangiographic study of circulation in the villi and intervillous space of isolated human placental cotyledon kept viable by perfusion. J. Physiol. (Paris) 59, 277 (1967).
14. Miller, R.K. Human placenta in vitro: characterization during 12 h of dual perfusion. Contrib. Gynecol. Obstet. 13, 77-84 (1985). (Pubitemid 15120216)
15. Sweiry, J.H. & Yudilevich, D.L. Characterization of folate uptake in guinea pig placenta. Am. J. Physiol. 254, C735-C743 (1988).
16. Hutson, J.R., Garcia-Bournissen, F., Davis, A. & Koren, G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin. Pharmacol. Ther. 90, 67-76 (2011).
17. Suzue, T. Physiological activities of late-gestation rat fetuses in vitro. Neurosci. Res. 14, 145-157 (1992).
18. Staud, F. et al. Corticosterone transfer and metabolism in the dually perfused rat placenta: effect of 11β-hydroxysteroid dehydrogenase type 2. Placenta 27, 171-180 (2006). (Pubitemid 41763459)
19. Schröder, H. & Leichtweiss, H.P. Perfusion rates and the transfer of water across isolated guinea pig placenta. Am. J. Physiol. 232, H666-H670 (1977). (Pubitemid 8207702)
20. Pienimäki, P. et al. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia 38, 309-316 (1997). (Pubitemid 27147644)
21. Penfold, P., Drury, L., Simmonds, R. & Hytten, F.E. Studies of a single placental cotyledon in vitro: I. The preparation and its viability. Placenta 2, 149-154 (1981). (Pubitemid 11143742)
22. Pollex, E.K., Feig, D.S., Lubetsky, A., Yip, P.M. & Koren, G. Insulin glargine safety in pregnancy: a transplacental transfer study. Diabetes Care 33, 29-33 (2010).
23. Halkoaho, A. et al. Ethical aspects of human placental perfusion: interview of the mothers donating placenta. Placenta 31, 686-690 (2010).
24. Staud, F. et al. Expression and transport activity of breast cancer resistance protein (Bcrp/Abcg2) in dually perfused rat placenta and HRP-1 cell line. J. Pharmacol. Exp. Ther. 319, 53-62 (2006). (Pubitemid 44455110)
25. Vähäkangas, K. & Myllynen, P. Experimental methods to study human transplacental exposure to genotoxic agents. Mutat. Res. 608, 129-135 (2006). (Pubitemid 44311606)
26. Heikkine, T., Ekblad, U. & Laine, K. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG 109, 1003-1008 (2002). (Pubitemid 35279130)
27. Di Santo, S. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7-24 h. Placenta 24, 882-894 (2003). (Pubitemid 37184817)
28. Suzue, T. Perfusion method and their physiological activities. Neurosci. Res. 21, 173-176 (1994).
29. Bajoria, R. & Contractor, S.F. Effect of surface charge of small unilamellar liposomes on uptake and transfer of carboxyfluorescein across the perfused human term placenta. Pediatr. Res. 42, 520-527 (1997). (Pubitemid 27411161)
30. Tohyama, K., Kusuhara, H. & Sugiyama, Y. Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145, 4384-4391 (2004). (Pubitemid 39120588)
31. Bonnin, A. & Levitt, P. Placental source for 5-HT that tunes fetal brain development. Neuropsychopharmacology 37, 299-300 (2012).
32. Bonnin, A. & Levitt, P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 197, 1-7 (2011).
33. Okada, Y. et al. Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat. Biotechnol. 25, 233-237 (2007). (Pubitemid 46227123)
34. Wenzel, P.L. & Leone, G. Expression of Cre recombinase in early diploid trophoblast cells of the mouse placenta. Genesis 134, 129-134 (2007). (Pubitemid 46623024)
35. Renaud, S.J., Karim Rumi, M.A. & Soares, M.J. Review: Genetic manipulation of the rodent placenta. Placenta 32 (suppl. 2), S130-S135 (2011).
36. Morioka, Y., Isotani, A., Oshima, R.G., Okabe, M. & Ikawa, M. Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/loxP system. Genesis 47, 793-798 (2009).
37. Zenclussen, A.C., Olivieri, D.N., Dustin, M.L. & Tadokoro, C.E. In vivo multiphoton microscopy technique to reveal the physiology of the mouse placenta. Am. J. Reprod. Immunol. 1600, 1-8 (2012).
38. Sitras, V., Fenton, C., Paulssen, R., Vårtun, Å. & Acharya, G. Differences in gene expression between first and third trimester human placenta: a microarray study. PLoS ONE 7, e33294 (2012).
39. Watson, E.D. & Cross, J.C. Development of structures and transport functions in the mouse placenta. Physiology 20, 180-193 (2005). (Pubitemid 40807056)
40. Mikheev, A.M. et al. Profiling gene expression in human placentae of different gestational ages: an OPRU network and UW SCOR study. Reprod. Sci. 15, 866-877 (2008).
41. Battaglia, F.C. & Regnault, T.R. Placental transport and metabolism of amino acids. Placenta 22, 145-161 (2001). (Pubitemid 32537032)
42. Pacifici, G.M. Placental transfer of drugs administered to the mother. Clin. Pharmacokinet. 28, 235-269 (1995).
43. Bell, A.W. Placental transport of nutrients and its implications for fetal growth. J. Reprod. Fertil. Suppl. 54, 401-410 (1999).
44. Apgar, V. & Papper, M.E. Transmission of drugs across the placenta. Anesth. Analg. 31, 309-320 (1951).
45. Hay, W.W. Placental transport of nutrients to the fetus. Horm. Res. 42, 215-222 (1994).
46. Battaglia, F.C. Placental transport: a function of permeability and perfusion. Am. J. Clin. Nutr. 85, 591S-597S (2007). (Pubitemid 46220967)
47. Coan, P.M. et al. Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J. Physiol. 586, 4567-4576 (2008).
48. Coan, P.M. et al. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J. Physiol. 588, 527-538 (2010).
49. Devaskar, S.U. Expression of genes involved in placental glucose uptake and transport in the nonobese diabetic mouse pregnancy. Am. J. Obstet. Gynecol. 171, 1316-1323 (1994). (Pubitemid 24365736)
50. Boyd, J.D. & Hamilton, W.J. Development and structure of the human placenta from the end of the 3rd month of gestation. J. Obstet. Gynaecol. Br. Commonw. 74, 161-226 (1967).
51. Hamilton, W.J. Trophoblast in human uterno-placental arteries. Nature 212, 906-908 (1966).
52. Kaufmann, P. & Stegner, H.E. Functional differentiation of the human placental syncytiotrophoblast. Z. Zellforsch. Mikrosk. Anat. 135, 361-382 (1972).
53. Boyd, J.D. Observations on the vacuolar structure of the human syncytiotrophoblast. Z. Zellforsch. Mikrosk. Anat. 88, 57-79 (1968).
54. Coan, P.M., Ferguson-Smith, A.C. & Burton, G.J. Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol. Reprod. 70, 1806-1813 (2004). (Pubitemid 38715638)
55. Brown, A.S. et al. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol. Psychiatry 49, 473-486 (2001). (Pubitemid 32226406)
56. Enayati, M. et al. Maternal infection during late pregnancy increases anxiety- and depression-like behaviors with increasing age in male offspring. Brain Res. Bull. 87, 295-302 (2012).
57. Lau, C. Fetal programming of adult disease: implications for prenatal care. Obstet. Gynecol. 117, 978-985 (2011).
58. Nathanielsz, P.W. Fetal programming: from gene to functional systems - an overview. J. Physiol. 547, 3-4 (2003). (Pubitemid 36285155)
59. Stolp, H., Neuhaus, A., Sundramoorthi, R. & Molnár, Z. The long and the short of it: gene and environment interactions during early cortical development and consequences for long-term neurological disease. Front. Psychiatry 3, 50 (2012).
60. Mueller, B.R. & Bale, T.L. Sex-specific programming of offspring emotionality after stress early in pregnancy. J. Neurosci. 28, 9055-9065 (2008).
61. Myatt, L. Placental adaptive responses and fetal programming. J. Physiol. 572, 25-30 (2006).
62. Jansson, T. & Powell, T.L. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin. Sci. 113, 1-13 (2007). (Pubitemid 47066020)
63. Ponder, K.L. et al. Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming. Dev. Psychol. 53, 711-723 (2011).
64. Gilligan, J., Tong, M., Longato, L., de la Monte, S.M. & Gundogan, F. Precision-cut slice culture method for rat placenta. Placenta 33, 67-72 (2012).
65. Rennie, M.Y., Whiteley, K.J., Kulandavelu, S., Adamson, S.L. & Sled, J.G. 3D visualisation and quantification by microcomputed tomography of late gestational changes in the arterial and venous feto-placental vasculature of the mouse. Placenta 28, 833-840 (2007). (Pubitemid 47074380)
66. Cox, B. et al. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol. Syst. Biol. 5, 279 (2009).
67. Georgiades, P., Ferguson-Smith, A.C. & Burton, G.J. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23, 3-19 (2002). (Pubitemid 41110436)
68. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568 (1999). (Pubitemid 29473320)
69. Buja, L.M. & Entman, M.L. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98, 1355-1357 (1998). (Pubitemid 28462793)
70. Jia, Z., Chen, Q. & Qin, H. Ischemia-induced apoptosis of intestinal epithelial cells correlates with altered integrin distribution and disassembly of f-actin triggered by calcium overload. J. Biomed. Biotechnol. 2012, 1-10 (2012).
71. Killinger, W.A.J., Dorofi, D.B., Keagy, B.A. & Johnson, G.J. Endothelial cell preservation using organ storage solutions. Transplantation 53, 979-982 (1992).
72. Hilgers, R.H.P. et al. Uterine artery structural and functional changes during pregnancy in tissue kallikrein-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1826-1832 (2003). (Pubitemid 37254870)
73. Mu, J. & Adamson, S.L. Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am. J. Physiol. Heart Circ. Physiol. 5, 1421-1428 (2006).
74. Osol, G. & Mandala, M. Maternal uterine vascular remodeling during pregnancy. Physiology 24, 58-71 (2009).
75. MacLennan, M.J. & Keller, B.B. Umbilical arterial blood flow in the mouse embryo during development and following acutely increased heart rate. Ultrasound Med. Biol. 25, 361-370 (1999). (Pubitemid 29191181)
76. Kay, H.H., Zhu, S. & Tsoi, S. Hypoxia and lactate production in trophoblast cells. Placenta 28, 854-860 (2007). (Pubitemid 47074378)
77. Dunwoodie, S.L. The role of hypoxia in development of the mammalian embryo. Dev. Cell 17, 755-773 (2009).
78. Tissot van Patot, M.C. et al. Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, 166-172 (2010).
79. Hernandez, L.D. et al. Caspases and cell death. In Encyclopedia of Life Sciences. (John Wiley & Sons, 2001).
80. Lamkanfi, M., Festjens, N., Declercq, W., Vanden Berghe, T. & Vandenabeele, P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14, 44-55 (2007). (Pubitemid 44911893)
81. Edison, N. et al. The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo. Cell Death Differ. 19, 356-368 (2012).
82. Schwartz, S.M. Cell death and the caspase cascade. Circulation 97, 227-229 (1998). (Pubitemid 28067304)
83. Mu, J. et al. Apoptosis and related proteins in placenta of intrauterine fetal death in prostaglandin F receptor-deficient mice. Biol. Reprod. 68, 1968-1974 (2003). (Pubitemid 36686986)